SCHEMBL6984569

SCHEMBL6984569

CN(C)Cc1ccc(N/C(=C2\C(=O)Nc3ccc(C(=O)N(C)C)cc32)c2ccccc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 1/20 0.42
ROCK2 O75116 5/20 0.39
SLC2A1 P11166 1/20 0.37
CYP3A4 P08684 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
LSS P48449 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
PDPK1 O15530 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP2C19 P33261 1/20 0.35
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
PAK4 O96013 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984575 1.00 JAK3 (0.42) JAK3ROCK2SLC2A1CYP3A4HDAC3
SCHEMBL6979863 0.93 ACHE (0.44) JAK3HDAC1BCHEACHE
SCHEMBL6979865 0.93 ACHE (0.44) JAK3HDAC1BCHEACHE
SCHEMBL8188416 0.93 MEN1 (0.46) ROCK2HDAC1MEN1KMT2A
SCHEMBL8188423 0.93 MEN1 (0.46) ROCK2HDAC1MEN1KMT2A
SCHEMBL7984825 0.92 ROCK2 (0.41) JAK3ROCK2SLC2A1CYP3A4HDAC3
SCHEMBL4611892 0.91 ROCK2 (0.40) JAK3ROCK2SLC2A1PDPK1MEN1
SCHEMBL14587215 0.91 ROCK2 (0.40) JAK3ROCK2SLC2A1PDPK1MEN1
SCHEMBL4611898 0.91 ROCK2 (0.40) JAK3ROCK2SLC2A1PDPK1MEN1
SCHEMBL6971260 0.91 JAK3 (0.41) JAK3ROCK2PDPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071665-B1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-10-01 EP disclosed
US-6169106-B1 ANTITUMOUR AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-01-02 US disclosed